Harvard Bioscience (HBIO) Other Operating Expenses (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Other Operating Expenses of $3.2 million for Q1 2026, down 93.84% year-over-year from $51.6 million in Q1 2025, and up 175.18% quarter-over-quarter from -$4.2 million in Q4 2025.
Harvard Bioscience (HBIO) Other Operating Expenses (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Other Operating Expenses for 17 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses fell 93.84% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $7.9 million (down 87.42% YoY), while the FY2025 annual figure was $61.5 million, up 256.25% from the prior year.
- Other Operating Expenses advanced to $3.2 million in Q1 2026 per HBIO's latest filing, from -$4.2 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $51.6 million in Q1 2025 and bottomed at -$4.7 million in Q4 2023.
- Historically, Other Operating Expenses has averaged $6.8 million across 5 years, with a median of $4.5 million in 2022.
- On a YoY basis, Other Operating Expenses climbed as much as 895.43% in 2025 and fell as far as 211.28% in 2025.
- Harvard Bioscience's Other Operating Expenses stood at $4.5 million in 2022, then tumbled by 204.18% to -$4.7 million in 2023, then surged by 181.48% to $3.8 million in 2024, then tumbled by 211.28% to -$4.2 million in 2025, then jumped by 175.18% to $3.2 million in 2026.
- Business Quant data shows HBIO's Other Operating Expenses at $3.2 million in Q1 2026, -$4.2 million in Q4 2025, and $5.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.27 Mn |
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | -4.23 Mn |
| Sep 30, 2025 | 5.47 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | 51.60 Mn |
| Dec 31, 2024 | 3.80 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 3.81 Mn |
| Mar 31, 2024 | 5.18 Mn |
| Dec 31, 2023 | -4.67 Mn |
| Sep 30, 2023 | 7.09 Mn |
| Jun 30, 2023 | 7.57 Mn |
| Mar 31, 2023 | 4.29 Mn |
| Dec 31, 2022 | 4.48 Mn |
| Sep 30, 2022 | 7.39 Mn |
| Jun 30, 2022 | 8.06 Mn |
| Mar 31, 2022 | 4.69 Mn |
| Dec 31, 2021 | -5.35 Mn |
| Sep 30, 2021 | 7.64 Mn |